Sign in →

Test Code PFCEA Carcinoembryonic Antigen (CEA), Pleural Fluid

Important Note

Order GO23910 Generic Orderable/Misc Test

Reporting Name

CEA, Pleural Fluid

Useful For

An adjuvant to cytology and imaging studies to differentiate between nonmalignant and malignant causes of pleural effusions

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Pleural Fluid


Specimen Required


Sources: Pleural fluid, thoracentesis fluid

Container/Tube: Plain, plastic, screw-top tube

Specimen Volume: 2 mL


Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Pleural Fluid Frozen (preferred) 90 days
  Refrigerated  14 days
  Ambient  7 days

Reference Values

An interpretive report will be provided.

Day(s) Performed

Monday through Saturday

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

82378

LOINC Code Information

Test ID Test Order Name Order LOINC Value
PFCEA CEA, Pleural Fluid 19169-2

 

Result ID Test Result Name Result LOINC Value
PCEA CEA, Pleural Fluid 19169-2
SITE9 Site 39111-0

Cautions

This test result should not be the sole basis for diagnosis. Carcinoembryonic antigen (CEA) and other tumor markers are not specific for malignancy and CEA testing has limited utility when used as the sole diagnostic test. Test results should always be correlated with cytology, imaging, and other clinical findings.

 

A low or negative CEA result may be misleading, as certain malignancies do not secrete CEA and will not produce elevated CEA concentrations in pleural effusions. Negative results should be interpreted with caution in patients who have, or are suspected of having, a non-CEA-secreting malignancy or who have cancer of unknown primary origin. Alternative methodologies, including cytology, imaging, and other tumor marker testing should be considered.

 

Carcinoembryonic antigen concentrations have been reported to be elevated in pleural fluid as a consequence of certain nonmalignant conditions, including liver cirrhosis, pancreatitis, complicated parapneumonic effusions and empyemas, and, rarely, tuberculosis. Results should be interpreted with caution in patients with those conditions.

 

In rare cases, some individuals can develop antibodies to mouse or other animal antibodies (often referred to as human anti-mouse antibodies [HAMA] or heterophile antibodies), which may cause interference in some immunoassays. Caution should be used in interpretation of results, and the laboratory should be alerted if the result does not correlate with the clinical presentation.

Report Available

1 to 3 days

Reject Due To

Gross hemolysis Reject

NY State Approved

Yes

Method Name

Immunoenzymatic Assay

Forms

If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Secondary ID

83742